SG11201811144WA - Steviol glycoside compositions for oral ingestion or use - Google Patents

Steviol glycoside compositions for oral ingestion or use

Info

Publication number
SG11201811144WA
SG11201811144WA SG11201811144WA SG11201811144WA SG11201811144WA SG 11201811144W A SG11201811144W A SG 11201811144WA SG 11201811144W A SG11201811144W A SG 11201811144WA SG 11201811144W A SG11201811144W A SG 11201811144WA SG 11201811144W A SG11201811144W A SG 11201811144WA
Authority
SG
Singapore
Prior art keywords
international
compositions
minnesota
steviol
steviol glycoside
Prior art date
Application number
SG11201811144WA
Other languages
English (en)
Inventor
Ting Liu Carlson
Dan S Gaspard
Michael Alan Mortenson
Original Assignee
Cargill Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cargill Inc filed Critical Cargill Inc
Publication of SG11201811144WA publication Critical patent/SG11201811144WA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • A23L27/30—Artificial sweetening agents
    • A23L27/33—Artificial sweetening agents containing sugars or derivatives
    • A23L27/36—Terpene glycosides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52—Adding ingredients
    • A23L2/60—Sweeteners
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L27/00—Spices; Flavouring agents or condiments; Artificial sweetening agents; Table salts; Dietetic salt substitutes; Preparation or treatment thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/256—Polyterpene radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Seasonings (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
SG11201811144WA 2016-06-17 2017-06-16 Steviol glycoside compositions for oral ingestion or use SG11201811144WA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201662351640P 2016-06-17 2016-06-17
PCT/US2017/037868 WO2017218888A1 (fr) 2016-06-17 2017-06-16 Compositions de glycosides de stéviol pour ingestion ou utilisation orale

Publications (1)

Publication Number Publication Date
SG11201811144WA true SG11201811144WA (en) 2019-01-30

Family

ID=60663380

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201811144WA SG11201811144WA (en) 2016-06-17 2017-06-16 Steviol glycoside compositions for oral ingestion or use
SG10202012673SA SG10202012673SA (en) 2016-06-17 2017-06-16 Steviol glycoside compositions for oral ingestion or use

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG10202012673SA SG10202012673SA (en) 2016-06-17 2017-06-16 Steviol glycoside compositions for oral ingestion or use

Country Status (9)

Country Link
US (2) US20190320699A1 (fr)
EP (1) EP3478700A4 (fr)
JP (1) JP7107855B2 (fr)
CN (1) CN109641929B (fr)
AU (2) AU2017285444B2 (fr)
BR (1) BR112018076294B1 (fr)
CA (1) CA3027730A1 (fr)
SG (2) SG11201811144WA (fr)
WO (1) WO2017218888A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107105734A (zh) * 2014-09-19 2017-08-29 谱赛科有限责任公司 高纯度甜菊醇糖苷
CN107613785A (zh) 2015-05-20 2018-01-19 嘉吉公司 糖苷组合物
US20230132596A1 (en) 2016-11-14 2023-05-04 Purecircle Usa Inc. Stevia-derived molecules, methods of obtaining such molecules, and uses of the same
JP2021518369A (ja) * 2018-03-16 2021-08-02 ピュアサークル ユーエスエー インコーポレイテッド 高純度ステビオール配糖体
KR20210027270A (ko) * 2018-06-08 2021-03-10 퓨어써클 유에스에이 잉크. 고순도 스테비올 글리코사이드
JP2022513616A (ja) * 2018-11-27 2022-02-09 ピュアサークル ユーエスエー インコーポレイテッド 高純度ステビオールグリコシド
WO2020123877A1 (fr) 2018-12-12 2020-06-18 Conagen Inc. Production biosynthétique de glycosides de stéviol variants
CN113508124A (zh) * 2019-02-15 2021-10-15 谱赛科美国股份有限公司 高纯度甜菊醇糖苷

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3009508B1 (fr) * 2011-08-08 2020-11-25 Evolva SA Production recombinante de glycosides de stéviol
CN103159808B (zh) * 2011-12-09 2017-03-29 上海泓博智源医药股份有限公司 一种制备天然甜味剂的工艺方法
ES2971273T3 (es) * 2011-12-19 2024-06-04 Coca Cola Co Bebida que comprende rebaudiósido X
CN105051195B (zh) * 2013-02-06 2019-09-06 埃沃尔瓦公司 用于提高莱鲍迪苷d和莱鲍迪苷m之产生的方法
CA2939784C (fr) * 2014-02-18 2023-01-24 Mcneil Nutritionals, Llc Procede de separation, d'isolement et de caracterisation des glycosides du steviol
MX2017001859A (es) * 2014-08-11 2017-04-11 Evolva Sa Produccion de glicosidos de esteviol en hospederos recombinantes.
CN107105734A (zh) * 2014-09-19 2017-08-29 谱赛科有限责任公司 高纯度甜菊醇糖苷
US11584769B2 (en) * 2014-11-29 2023-02-21 The Coca-Cola Company Diterpene glycosides, compositions and purification methods
CN107249356B (zh) * 2014-12-17 2021-08-06 嘉吉公司 用于口服摄入或使用的甜菊醇糖苷化合物、组合物以及用于增强甜菊醇糖苷溶解度的方法
SG11201705606PA (en) * 2015-01-30 2017-08-30 Evolva Sa Production of steviol glycosides in recombinant hosts
EP3458599A1 (fr) * 2016-05-16 2019-03-27 Evolva SA Production de glycosides de stéviol dans des hôtes de recombinaison

Also Published As

Publication number Publication date
CA3027730A1 (fr) 2017-12-21
US20220295849A1 (en) 2022-09-22
WO2017218888A1 (fr) 2017-12-21
AU2021257896B2 (en) 2023-09-21
AU2017285444B2 (en) 2021-07-29
JP2019517811A (ja) 2019-06-27
AU2021257896A1 (en) 2021-11-25
AU2017285444A1 (en) 2019-01-17
CN109641929A (zh) 2019-04-16
CN109641929B (zh) 2024-01-02
BR112018076294A2 (pt) 2019-03-26
BR112018076294B1 (pt) 2022-12-27
EP3478700A4 (fr) 2020-04-22
JP7107855B2 (ja) 2022-07-27
US20190320699A1 (en) 2019-10-24
EP3478700A1 (fr) 2019-05-08
SG10202012673SA (en) 2021-01-28

Similar Documents

Publication Publication Date Title
SG11201811144WA (en) Steviol glycoside compositions for oral ingestion or use
SG11201804542YA (en) Steviol glycoside compositions for oral ingestion or use
SG11201811273RA (en) Steviol glycoside compositions for oral ingestion or use
SG11201809559UA (en) Substituted pyridines as inhibitors of dnmt1
SG11201901126UA (en) Combination therapy for cancer
SG11201909155VA (en) Ask1 inhibitor compounds and uses thereof
SG11201811338VA (en) A novel botulinum neurotoxin and its derivatives
SG11201805300QA (en) Heterocyclic compounds as immunomodulators
SG11201903480TA (en) Cell culture device system and methods of use thereof
SG11201811184UA (en) Lag -3 binding members
SG11201906795SA (en) Novel plant cells, plants, and seeds
SG11201901941YA (en) High purity rna compositions and methods for preparation thereof
SG11201907820SA (en) Inhibitors of (alpha-v)(beta-6) integrin
SG11201908280SA (en) "chimeric molecules and uses thereof"
SG11201808724SA (en) Anti-tim-3 antibodies and compositions
SG11201806485RA (en) Pyrrolobenzodiazepine conjugates
SG11201900554YA (en) Spiro-lactam nmda modulators and methods of using same
SG11201804673WA (en) Novel anti-claudin antibodies and methods of use
SG11201908325PA (en) Process for the preparation of glucuronide drug-linkers and intermediates thereof
SG11201900633XA (en) Piperidine cxcr7 receptor modulators
SG11201900558RA (en) Spiro-lactam nmda receptor modulators and uses thereof
SG11201809908TA (en) Stabilized glycopeptide antibiotic formulations
SG11201806284TA (en) Low pressure separator having an internal divider and uses therefor
SG11201809374VA (en) Cd40l-fc fusion polypeptides and methods of use thereof
SG11201900551WA (en) Spiro-lactam nmda receptor modulators and uses thereof